Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.
VG, E.H., M, G., JM, R., B, M., P, C., W, M., H, C., J, F., A, N., & VE, S. (2026). Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-026-05687-0
VG EH, M G, JM R, B M, P C, W M, et al. Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.. Journal of neuro-oncology. 2026; doi: 10.1007/s11060-026-05687-0
VG EH, M G, JM R, et al. Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.[J]. Journal of neuro-oncology. 2026. DOI: 10.1007/s11060-026-05687-0.
@article{vg2026,
author = {El-Hajj VG and Gharios M and Roy JM and Musmar B and Carey P and Mualem W and Chanbour H and Feghali J and Naik A and Staartjes VE},
title = {Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.},
journal = {Journal of neuro-oncology},
year = {2026},
doi = {10.1007/s11060-026-05687-0},
note = {PMID: 42364002},
}
TY - JOUR AU - El-Hajj VG AU - Gharios M AU - Roy JM AU - Musmar B AU - Carey P AU - Mualem W AU - Chanbour H AU - Feghali J AU - Naik A AU - Staartjes VE TI - Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature. T2 - Journal of neuro-oncology PY - 2026 DO - 10.1007/s11060-026-05687-0 AN - PMID:42364002 ER -
INTRODUCTION: Tumors involving dural venous sinuses can lead to venous outflow obstruction and secondary intracranial hypertension. While surgical resection can decompress the sinus, such procedures carry significant risks. With the success of endovascular interventions for idiopathic intracranial hypertension (IIH), venous sinus stenting (VSS) and angioplasty have emerged as potential treatments for tumor-related sinus stenosis. However, evidence remains limited and dispersed. This systematic review aimed to synthesize the available literature on the safety and efficacy of endovascular treatment for tumor-related venous sinus obstruction. METHODS: A systematic search of PubMed, Embase, and Web of Science was conducted from database inception to November 2025. Eligible studies included any report describing endovascular treatment (VSS and/or angioplasty) for tumor-related venous sinus obstruction, whether due to tumor invasion or compression, or even stenosis following surgery or radiotherapy. Data on patient demographics, tumor characteristics, procedural details, and outcomes were extracted and summarized descriptively. RESULTS: Twenty studies comprising 57 patients were included. Most patients were female (65%) with a mean age of 48 years. Meningioma represented the most common underlying tumor (75%). The majority of obstructions resulted from tumor compression or invasion (86%), and most patients underwent VSS alone (74%), while the rest underwent VSS and angioplasty (23%). No periprocedural complications were reported. Mean trans-stenotic pressure gradient decreased by 10 ± 9 mmHg post-treatment and mean lumbar opening pressure decreased by 11 ± 12 cmH2O. Clinical improvement was reported in 63% of patients, including resolution or improvement of papilledema in 94% and vision changes in 94%. Repeat intervention was required in 28% of cases, and only about half of patients achieved further improvement after reintervention. CONCLUSION: Endovascular therapy for tumor-related venous sinus stenosis appears safe and effective, leading to meaningful pressure reduction and symptomatic improvement in two-thirds of patients. These findings support VSS as a viable adjunct or alternative to surgery in selected patients. Nonetheless, the certainty of evidence remains very low, and current data cannot establish definitive conclusions.